Kineta, Inc. (KA) は上場企業です ヘルスケア セクターの バイオテクノロジー 業界で事業展開. 本社所在地は Seattle, WA, アメリカ. 現CEOは Craig W. Philips.
KA を有する IPO日 2016-02-11, 11 名の正社員, に上場 NASDAQ Capital Marke, 時価総額 $7.05M.
Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.
